Suppr超能文献

血浆纤连蛋白异构体水平的变化可预测重症患者不同的临床结局。

Changes in plasma fibronectin isoform levels predict distinct clinical outcomes in critically ill patients.

作者信息

Peters John H, Grote Mark N, Lane Nancy E, Maunder Richard J

机构信息

Department of Medicine, Sacramento Medical Center, VA Northern California Health Care System, Mather, CA 95655.

出版信息

Biomark Insights. 2011;6:59-68. doi: 10.4137/BMI.S7204. Epub 2011 May 29.

Abstract

INTRODUCTION

Concentrations of the total pool of fibronectin in plasma (TFN), and the subset of this pool that contains the alternatively spliced EDA segment (A(+)FN), are both affected by disease processes, and the latter pool has gained a reputation as a biomarker for vascular injury. We therefore wished to determine if changes in either FN pool correlate with clinical outcomes in critically ill individuals.

METHODS

We analyzed a database for 57 patients with major trauma (n = 33) or sepsis syndrome (n = 24) in which plasma levels of TFN and A(+)FN had been measured at intervals, along with clinical parameters. Logistic regression analysis was performed to detect associations between predictive variables and three clinical outcomes: 1) the acute respiratory distress syndrome (ARDS), 2) milder acute lung injury designated acute hypoxemic respiratory failure (AHRF), and 3) survival to hospital discharge.

RESULTS

An increase in plasma TFN during the first 24 hours of intensive care unit (ICU) observation was negatively associated with progression to ARDS (odds ratio 0.98 per 1 microgram (μg)/ml increase, 95% CI (0.97, 1.00)) and AHRF (OR 0.97 per 1 μg/ml increase, (0.95, 0.99)), whereas an increase in A(+)FN over the first 24 hours was positively associated with progression to AHRF (OR 1.65 per 1 μg/ml increase, (1.04, 2.62)). Additionally, the ratio of the partial pressure of oxygen in arterial blood (PaO(2)) to the percentage of oxygen in inspired air (FIO(2)) after 24 hours was positively associated with survival (OR 1.01 per 1 unit increase in ratio, (1.00, 1.03)), along with change in A(+)FN (OR 1.30 per 1 μg/ml increase, (0.90, 1.88)).

CONCLUSIONS

Different FN isoforms may constitute predictive covariate markers for distinct clinical outcomes in critically ill patients. The data also suggest that early TFN accumulation in the circulation may confer a clinical benefit to patients at risk for acute lung injury.

摘要

引言

血浆中纤连蛋白总池(TFN)的浓度以及该池中包含可变剪接的EDA片段的子集(A(+)FN)均受疾病过程影响,且后一个池已成为血管损伤生物标志物而闻名。因此,我们希望确定任一纤连蛋白池的变化是否与危重症患者的临床结局相关。

方法

我们分析了一个包含57例严重创伤患者(n = 33)或脓毒症综合征患者(n = 24)的数据库,其中定期测量了TFN和A(+)FN的血浆水平以及临床参数。进行逻辑回归分析以检测预测变量与三种临床结局之间的关联:1)急性呼吸窘迫综合征(ARDS),2)较轻的急性肺损伤即急性低氧性呼吸衰竭(AHRF),以及3)存活至出院。

结果

在重症监护病房(ICU)观察的最初24小时内,血浆TFN升高与进展为ARDS呈负相关(每增加1微克(μg)/毫升,优势比为0.98,95%置信区间(0.97,1.00))以及与进展为AHRF呈负相关(每增加1μg/毫升,优势比为0.97,(0.95,0.99)),而在最初24小时内A(+)FN升高与进展为AHRF呈正相关(每增加1μg/毫升,优势比为1.65,(1.04,2.62))。此外,24小时后动脉血氧分压(PaO(2))与吸入气中氧百分比(FIO(2))的比值与存活呈正相关(比值每增加1个单位,优势比为1.01,(1.00,1.03)),以及与A(+)FN的变化呈正相关(每增加1μg/毫升,优势比为1.30,(0.90,1.88))。

结论

不同的纤连蛋白异构体可能构成危重症患者不同临床结局的预测协变量标志物。数据还表明,循环中早期TFN积累可能对有急性肺损伤风险的患者带来临床益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1871/3115635/07ea3492b2a6/bmi-1-2011-059f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验